Block Listing Update

RNS Number : 7387F

Futura Medical PLC

22 May 2017

 

For immediate release

22 May 2017

Futura Medical plc

("Futura" or "the Company")

Block Listing Update

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology today announces that an application has been made to the London Stock Exchange to extend its block listings of securities in respect of a total of 3,360,000 ordinary shares of 0.2 pence each (the "Ordinary Shares") which may arise pursuant to the exercise of options under its Unapproved Share Option Scheme ("USOS") and its EMI Share Option Scheme ("EMI").

Admission of the above additional shares to be block listed is expected to occur on or around 25 May 2017.

The Company makes the following update on its block listings, pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies. All figures relate to options over Ordinary Shares.

The table below provides further detail:

Name of company:	Futura Medical plc
Name of scheme(s):	USOS EMI
Period of return:	From:	25 November 2016
	To:	22 May 2017
Number and class of securities not issued under the scheme(s) at beginning of period	USOS:	1,156,321
	EMI:	1,364,141
	Total:	2,520,462
Number and class of securities admitted to the scheme(s) in the period	USOS:	1,466,208
	EMI:	1,893,792
	Total:	3,360,000
Number of securities issued under the scheme(s) during the period Number of securities lapsed under the scheme(s) during the period	USOS:	(176,419)
	EMI: USOS: EMI:	(236,543) - -
Balance of securities under the scheme(s) not yet issued at the end of the period	USOS:	2,446,110
	EMI:	3,021,390
	Total:	5,467,500
Number and class of securities originally admitted and the date of admission	USOS:	814,424 on 25 May 2011, 1,202,280 on 8 October 2013, 1,466,208 on 25 May 2017
	USOS Total:	3,482,912
	EMI:	1,520,576 on 25 May 2011, 1,467,720 on 8 October 2013, 1,893,792 on 25 May 2017
	EMI Total:	4,882,088
	Total:	8,365,000
Name of contact:	Derek Martin, Chief Financial Officer
Telephone number of contact:	[phone]

For further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
Email to: [e-mail]	www.futuramedical.com
N+1 Singer (Nominated Adviser and Broker)
Aubrey Powell / Liz Yong Corporate Finance	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Sophie Cowles / Stephanie Watson	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

BLRPGUUWAUPMGQG